Evidence map›Paper›PMID 39232095›Full record

SynthesisProstate cancer and prostatic diseases2025

Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) during robot-assisted radical prostatectomy: a systematic review and meta-analysis of comparative studies.

Francesco Ditonno, Eugenio Bologna, Leslie Claire Licari, Antonio Franco, Donato Cannoletta, Enrico Checcucci, Alessandro Veccia, Riccardo Bertolo, Simone Crivellaro, Francesco Porpiglia and 3 more

Abstract readSystematic ReviewMeta-AnalysisComparative Study
PubMed Publisher
In one paragraph

Synthesis in Prostate cancer and prostatic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Advances in Techniques in Radical Prostatectomy.Medicina (Kaunas, Lithuania) · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francesco DitonnoDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.ORCID http://orcid.org/0009-0005-0126-4731
Eugenio BolognaDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-1140-0590
Leslie Claire LicariDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.
Antonio FrancoDepartment of Urology, Rush University Medical Center, Chicago, IL, USA.
Donato CannolettaDepartment of Urology, University of Illinois at Chicago, Chicago, IL, USA.
Enrico CheccucciDepartment of Surgery, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.ORCID http://orcid.org/0000-0001-7901-5608
Alessandro VecciaDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.ORCID http://orcid.org/0000-0001-5947-3206
Riccardo BertoloDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.ORCID http://orcid.org/0000-0003-0260-4601
Simone CrivellaroDepartment of Urology, University of Illinois at Chicago, Chicago, IL, USA.
Francesco PorpigliaDivision of Urology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.
Cosimo De NunzioDepartment of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0002-2190-512X
Alessandro AntonelliDepartment of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.ORCID http://orcid.org/0000-0002-7455-8803
Riccardo AutorinoDepartment of Urology, Rush University Medical Center, Chicago, IL, USA. ricautor@gmail.com.ORCID http://orcid.org/0000-0001-7045-7725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo compare surgical, pathological, and functional outcomes of patients undergoing NeuroSAFE-guided RARP vs. RARP alone.

methodsIn February 2024, a literature search and assessment was conducted through PubMed

resultsOverall, seven studies met the inclusion criteria (one randomized clinical trial, one prospective non-randomized trial and five retrospective studies) and were eligible for SR and MA. A total of 4,207 patients were included in the MA, with 2247 patients (53%) undergoing RARP with the addition of NeuroSAFE, and 1 960 (47%) receiving RARP alone. The addition of NeuroSAFE enhanced the likelihood of receiving a nerve-sparing (NS) RARP (OR 5.49, 95% CI 2.48-12.12, I

conclusionAvailable evidence suggests that NeuroSAFE might represent a histologically based approach to NVB preservation, broadening the indications of NS RARP, reducing the likelihood of PSM and subsequent BCR. In addition, it might translate into better functional postoperative outcomes. However, the current body of evidence is mostly derived from non-randomized studies with a high risk of bias.

Indexed as

Frozen SectionsProstateProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresHumansMaleOrgan Sparing Treatments

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.